Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.

Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, Sherman ME, Lacey JV Jr, Gaudet MM, Burdette LA, Figueroa JD, Ciampa JG, Lissowska J, Peplonska B, Chanock SJ, Garcia-Closas M.

Carcinogenesis. 2010 May;31(5):827-33. doi: 10.1093/carcin/bgp328. Epub 2010 Jan 6.

2.

Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.

Olson SH, Bandera EV, Orlow I.

Am J Epidemiol. 2007 Feb 1;165(3):235-45. Epub 2006 Nov 16. Review.

PMID:
17110639
3.

Genetic variation in the androgen receptor gene and endometrial cancer risk.

Yang HP, Garcia-Closas M, Lacey JV Jr, Brinton LA, Lissowska J, Peplonska B, Chanock S, Gaudet MM.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):585-9. doi: 10.1158/1055-9965.EPI-08-0677. Epub 2009 Feb 3.

4.

Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.

Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV Jr, Le Marchand L, Levine DA, Liang X, Lissowska J, Lurie G, McGrath M, Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang YB, Yang HP, Zheng W, Olson SH.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7. doi: 10.1158/1055-9965.EPI-08-0689.

5.

Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.

Tao MH, Cai Q, Zhang ZF, Xu WH, Kataoka N, Wen W, Xiang YB, Zheng W, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):943-9.

6.

CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.

Hirata H, Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Rabban JT, Chen LM, Dahiya R.

Cancer. 2008 May 1;112(9):1964-73. doi: 10.1002/cncr.23392.

7.

Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.

Lundin E, Wirgin I, Lukanova A, Afanasyeva Y, Krogh V, Axelsson T, Hemminki K, Clendenen TV, Arslan AA, Ohlson N, Sieri S, Roy N, Koenig KL, Idahl A, Berrino F, Toniolo P, Hallmans G, Försti A, Muti P, Lenner P, Shore RE, Zeleniuch-Jacquotte A.

Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.

8.

CYP19 (aromatase) haplotypes and endometrial cancer risk.

Paynter RA, Hankinson SE, Colditz GA, Kraft P, Hunter DJ, De Vivo I.

Int J Cancer. 2005 Aug 20;116(2):267-74. Erratum in: Int J Cancer. 2008 Mar 15;122(6):1443.

9.

Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Liu ET, Liu J.

PLoS Genet. 2010 Jul 1;6(7):e1001012. doi: 10.1371/journal.pgen.1001012.

10.

Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.

Hosono S, Matsuo K, Ito H, Watanabe M, Hirose K, Nakanishi T, Tajima K, Tanaka H.

Asian Pac J Cancer Prev. 2011;12(10):2747-52.

11.

Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.

Ferlin A, Ganz F, Pengo M, Selice R, Frigo AC, Foresta C.

Endocr Relat Cancer. 2010 Jan 29;17(1):17-25. doi: 10.1677/ERC-09-0176. Print 2010 Mar.

PMID:
19776291
12.

Estrogen and progesterone-related gene variants and colorectal cancer risk in women.

Lin JH, Manson JE, Kraft P, Cochrane BB, Gunter MJ, Chlebowski RT, Zhang SM.

BMC Med Genet. 2011 May 31;12:78. doi: 10.1186/1471-2350-12-78.

13.

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer.

Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, Dennis J, Webb PM; Australian National Endometrial Cancer Study Group (ANECS), Gorman M, Martin L, Hodgson S; National Study of Endometrial Cancer Genetics Group (NSECG), Michailidou K, Tyrer JP, Maranian MJ, Hall P, Czene K, Darabi H, Li J, Fasching PA, Hein A, Beckmann MW, Ekici AB, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Zhao H, Depreeuw J, Schrauwen S, Amant F, Goode EL, Fridley BL, Dowdy SC, Winham SJ, Salvesen HB, Trovik J, Njolstad TS, Werner HM, Ashton K, Proietto T, Otton G, Carvajal-Carmona L, Tham E, Liu T, Mints M; for RENDOCAS, Scott RJ, McEvoy M, Attia J, Holliday EG, Montgomery GW, Martin NG, Nyholt DR, Henders AK, Hopper JL, Traficante N; AOCS Group, Ruebner M, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Lambrechts D, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Bolla MK, Wang Q, Bojesen SE, Shah M, Luben R, Khaw KT, Pharoah PD, Dunning AM, Tomlinson I, Dowsett M, Easton DF, Spurdle AB.

Endocr Relat Cancer. 2016 Feb;23(2):77-91. doi: 10.1530/ERC-15-0386. Epub 2015 Nov 16.

14.

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.

Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, Thun MJ, Albanes D, Altshuler D, Ardanaz E, Boeing H, Buring J, Burtt N, Calle EE, Chanock S, Clavel-Chapelon F, Colditz GA, Cox DG, Feigelson HS, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn JN, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Le Marchand L, Lenner P, Lund E, Panico S, Peeters PH, Pike MC, Riboli E, Tjonneland A, Travis R, Trichopoulos D, Wacholder S, Ziegler RG.

Cancer Res. 2007 Mar 1;67(5):1893-7. Epub 2007 Feb 26.

15.

Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine.

Sutherland HG, Champion M, Plays A, Stuart S, Haupt LM, Frith A, MacGregor EA, Griffiths LR.

Gene. 2017 Apr 5;607:36-40. doi: 10.1016/j.gene.2017.01.008. Epub 2017 Jan 13.

PMID:
28089731
16.

Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.

Trabert B, Schwartz SM, Peters U, De Roos AJ, Chen C, Scholes D, Holt VL.

Fertil Steril. 2011 Dec;96(6):1401-1406.e3. doi: 10.1016/j.fertnstert.2011.09.004. Epub 2011 Sep 28.

17.
18.

Genetic variation in CYP17 and endometrial cancer risk.

Gaudet MM, Lacey JV Jr, Lissowska J, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M.

Hum Genet. 2008 Mar;123(2):155-62. doi: 10.1007/s00439-007-0454-8. Epub 2008 Jan 3.

PMID:
18172694
19.

Variants in hormone biosynthesis genes and risk of endometrial cancer.

Olson SH, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, Wilcox H, Asya A, Modica I, Asad H, Soslow R, Zauber AG.

Cancer Causes Control. 2008 Nov;19(9):955-63. doi: 10.1007/s10552-008-9160-7. Epub 2008 Apr 25.

20.

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Tang L, Platek ME, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JKV, Santella RM, Hsing A, Figg WD, Lippman SM, Thompson IM, Ambrosone CB.

Carcinogenesis. 2018 Feb 9;39(2):125-133. doi: 10.1093/carcin/bgx144.

Supplemental Content

Support Center